Georgi Iskrov
Georgi Iskrov
Medical University of Plovdiv (Bulgaria) | Institute for Rare Diseases (Bulgaria)
Verified email at raredis.org
Title
Cited by
Cited by
Year
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe
M Cavazza, Y Kodra, P Armeni, M De Santis, J López-Bastida, ...
The European Journal of Health Economics 17 (1), 19-29, 2016
402016
Social/economic costs and quality of life in patients with haemophilia in Europe
M Cavazza, Y Kodra, P Armeni, M De Santis, J López-Bastida, ...
The European Journal of Health Economics, 1-13, 2016
402016
National registries of rare diseases in Europe: an overview of the current situation and experiences
D Taruscio, L Vittozzi, R Choquet, K Heimdal, G Iskrov, Y Kodra, ...
Public health genomics 18 (1), 20-25, 2015
362015
Challenges to orphan drugs access in Eastern Europe: The case of Bulgaria
G Iskrov, T Miteva-Katrandzhieva, R Stefanov
Health Policy 108 (1), 10-18, 2012
362012
Multicriteria decision analysis to support health technology assessment agencies: benefits, limitations, and the way forward
R Baltussen, K Marsh, P Thokala, V Diaby, H Castro, I Cleemput, M Garau, ...
Value in Health 22 (11), 1283-1288, 2019
342019
Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
A Angelis, P Kanavos, J López-Bastida, R Linertová, J Oliva-Moreno, ...
The European Journal of Health Economics 17 (1), 31-42, 2016
342016
Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe
K Chevreul, C Gandré, KB Brigham, J López-Bastida, R Linertová, ...
The European Journal of Health Economics, 1-10, 2016
302016
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
K Chevreul, M Michel, KB Brigham, J López-Bastida, R Linertová, ...
The European Journal of Health Economics 17 (1), 7-18, 2016
282016
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe
A Kuhlmann, T Schmidt, M Treskova, J Lopez-Bastida, R Linertova, ...
The European Journal of Health Economics 17 (1), 79-87, 2016
282016
Multi-criteria decision analysis for assessment and appraisal of orphan drugs
G Iskrov, T Miteva-Katrandzhieva, R Stefanov
Frontiers in public health 4, 214, 2016
272016
Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations
G Iskrov, R Stefanov
Orphan Drugs: Research and Reviews 4, 1-9, 2014
272014
Тhe economic burden and health-related quality of life associated with systemic sclerosis in France
K Chevreul, K Berg Brigham, C Gandré, L Mouthon, BRDR Network
Scand J Rheumatol 44 (3), 328-46, 2015
262015
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
M Péntek, L Gulácsi, V Brodszky, P Baji, I Boncz, G Pogány, ...
The European Journal of Health Economics, 1-10, 2016
242016
General knowledge and awareness on rare diseases among general practitioners in Bulgaria.
M Ts, R Jordanova, G Iskrov, R Stefanov
Georgian medical news, 16-19, 2011
182011
Social/economic costs and health-related quality of life in patients with scleroderma in Europe
J López-Bastida, R Linertová, J Oliva-Moreno, P Serrano-Aguilar, ...
The European Journal of Health Economics 17 (1), 109-117, 2016
162016
Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe
J López-Bastida, R Linertová, J Oliva-Moreno, M Posada-de-la-Paz, ...
The European Journal of Health Economics, 1-10, 2016
162016
Economic burden and health-related quality of life of patients with cystic fibrosis in Bulgaria
GG Iskrov, RS Stefanov, J López-Bastida, R Linertová, J Oliva-Moreno, ...
Folia medica 57 (1), 56-64, 2015
162015
Insight into reimbursement decision-making criteria in Bulgaria: implications for orphan drugs
GG Iskrov, RD Raycheva, RS Stefanov
Folia medica 55 (3-4), 80-86, 2013
152013
Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in Bulgaria
G Iskrov, R Stefanov
Frontiers in public health 3, 64, 2015
132015
RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases
D Taruscio, C Morciano, P Laricchiuta, P Mincarone, F Palazzo, CG Leo, ...
Orphanet Journal of Rare Diseases 9 (1), 1-1, 2014
132014
The system can't perform the operation now. Try again later.
Articles 1–20